Drug Type mRNA |
Synonyms- |
Target |
Action modulators |
Mechanism MnSOD modulators(superoxide dismutase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Aortic Aneurysm, Abdominal | Preclinical | Bermuda | 29 Jul 2024 | |
Atherosclerosis | Preclinical | Bermuda | 30 Oct 2022 |